Axon Enterprise, Inc. (NASDAQ:AXON) Stake Lowered by Sanctuary Wealth Management L.L.C.

Sanctuary Wealth Management L.L.C. decreased its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 0.6% in the 3rd quarter, Holdings Channel.com reports. The firm owned 9,385 shares of the biotechnology company’s stock after selling 56 shares during the quarter. Axon Enterprise comprises approximately 2.7% of Sanctuary Wealth Management L.L.C.’s investment portfolio, making the stock its 9th largest holding. Sanctuary Wealth Management L.L.C.’s holdings in Axon Enterprise were worth $3,750,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in AXON. Blue Trust Inc. lifted its holdings in shares of Axon Enterprise by 987.5% in the 2nd quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company’s stock valued at $27,000 after purchasing an additional 79 shares during the last quarter. Quent Capital LLC boosted its holdings in shares of Axon Enterprise by 1,875.0% in the third quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock valued at $32,000 after acquiring an additional 75 shares during the period. Asset Dedication LLC purchased a new position in shares of Axon Enterprise during the second quarter worth approximately $47,000. Friedenthal Financial acquired a new position in shares of Axon Enterprise in the 3rd quarter valued at $51,000. Finally, Cullen Frost Bankers Inc. purchased a new stake in Axon Enterprise in the 2nd quarter valued at $59,000. 79.08% of the stock is owned by institutional investors and hedge funds.

Axon Enterprise Price Performance

Shares of Axon Enterprise stock traded up $134.43 on Friday, hitting $603.18. The company’s stock had a trading volume of 3,966,980 shares, compared to its average volume of 488,426. The company has a quick ratio of 2.52, a current ratio of 2.88 and a debt-to-equity ratio of 0.35. The firm has a fifty day moving average price of $414.16 and a 200-day moving average price of $347.27. Axon Enterprise, Inc. has a 52-week low of $212.88 and a 52-week high of $611.88. The company has a market capitalization of $45.58 billion, a P/E ratio of 155.86, a price-to-earnings-growth ratio of 15.15 and a beta of 0.94.

Analyst Ratings Changes

AXON has been the topic of a number of recent research reports. Bank of America began coverage on shares of Axon Enterprise in a research note on Wednesday, July 17th. They issued a “buy” rating and a $380.00 price objective on the stock. Needham & Company LLC upped their price objective on Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research note on Friday. Robert W. Baird lifted their target price on shares of Axon Enterprise from $440.00 to $460.00 and gave the company an “outperform” rating in a report on Monday, November 4th. Jefferies Financial Group began coverage on shares of Axon Enterprise in a report on Wednesday, July 17th. They set a “buy” rating and a $385.00 price target for the company. Finally, Northland Securities lifted their price objective on Axon Enterprise from $330.00 to $365.00 and gave the company an “outperform” rating in a report on Thursday, August 8th. Two investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $412.42.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, CFO Brittany Bagley sold 4,338 shares of the stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $378.95, for a total transaction of $1,643,885.10. Following the sale, the chief financial officer now owns 98,825 shares in the company, valued at approximately $37,449,733.75. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In related news, CFO Brittany Bagley sold 4,338 shares of the business’s stock in a transaction dated Thursday, September 12th. The shares were sold at an average price of $378.95, for a total value of $1,643,885.10. Following the completion of the transaction, the chief financial officer now owns 98,825 shares of the company’s stock, valued at approximately $37,449,733.75. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the firm’s stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $373.03, for a total transaction of $167,863.50. Following the sale, the director now directly owns 7,379 shares in the company, valued at $2,752,588.37. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 369,172 shares of company stock valued at $136,270,842 over the last quarter. Corporate insiders own 6.10% of the company’s stock.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.